Effect of bioflavonoids on vincristine transport across blood–brain barrier

2000/05/01 by Yoshiharu Mitsunaga, Hitomi Takanaga, Hirotami Matsuo +4 · 24 citations
Chemistry · Medicine · Pharmacology, Toxicology and Pharmaceutics · #Antioxidant #Biochemistry #Biology #Blood–brain barrier #Chemistry #Cholesterol and Lipid Metabolism #Drug Transport and Resistance Mechanisms #Endocrinology #Flavonoid #Ginger and Zingiberaceae research #Hesperetin #In vivo #Internal medicine #Medicine #Molecular biology #Naringenin #P-glycoprotein #Pharmacology #Quercetin #Rutin #Vincristine

paper · doi:10.1016/s0014-2999(00)00180-1

openalex publication_date 2000/05/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Cited by

• Traigo noticias de un homenaje y de varias definiciones
• Solubility, stability, physicochemical characteristics and in vitro ocular tissue permeability of hesperidin: a natural bioflavonoid. [europepmc]
• Quercetin as a potential modulator of P-glycoprotein expression and function in cells of human pancreatic carcinoma line resistant to daunorubicin. [europepmc]
• Improving cancer chemotherapy with modulators of ABC drug transporters. [europepmc]
• Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways. [europepmc]
• South Asian Medicinal Compounds as Modulators of Resistance to Chemotherapy and Radiotherapy. [europepmc]
• Impact of quercetin‑induced changes in drug‑metabolizing enzyme and transporter expression on the pharmacokinetics of cyclosporine in rats. [europepmc]
• Natural flavonoids silymarin and quercetin improve the brain distribution of co-administered P-gp substrate drugs. [europepmc]
• Polyphenols Beyond Barriers: A Glimpse into the Brain. [europepmc]
• Biomimetic synthesis and HPLC-ECD analysis of the isomers of dracocephins A and B. [europepmc]
• Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition. [europepmc]
• Phytotherapeutics: The Emerging Role of Intestinal and Hepatocellular Transporters in Drug Interactions with Botanical Supplements. [europepmc]
• Considerations for the Use of Polyphenols as Therapies in Neurodegenerative Diseases. [europepmc]
• Inhibitory Effect of Berberine on Broiler P-glycoprotein Expression and Function: In Situ and In Vitro Studies. [europepmc]
• Synthesis of Daidzein Glycosides, α-Tocopherol Glycosides, Hesperetin Glycosides by Bioconversion and Their Potential for Anti-Allergic Functional-Foods and Cosmetics. [europepmc]
• Molecular mechanisms of action of hesperidin in cancer: Recent trends and advancements. [europepmc]
• Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug-Drug Interaction Studies. [europepmc]
• Evaluation of the Mrp2-mediated flavonoid-drug interaction potential of quercetin in rats and in vitro models. [europepmc]
• Identification of potential therapeutic target of naringenin in breast cancer stem cells inhibition by bioinformatics and in vitro studies. [europepmc]
• Impacts of Drug Interactions on Pharmacokinetics and the Brain Transporters: A Recent Review of Natural Compound-Drug Interactions in Brain Disorders. [europepmc]
• Polyphenols in the Mediterranean Diet: From Dietary Sources to microRNA Modulation. [europepmc]
• Natural Compounds in Glioblastoma Therapy: Preclinical Insights, Mechanistic Pathways, and Outlook. [europepmc]
• Uptake and Transport of Naringenin and Its Antioxidant Effects in Human Intestinal Epithelial Caco-2 Cells. [europepmc]
• Much More than Nutrients: The Protective Effects of Nutraceuticals on the Blood-Brain Barrier in Diseases. [europepmc]
• Plants, Pills, and the Brain: Exploring Phytochemicals and Neurological Medicines. [europepmc]